A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia (Q33570221)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 December 2014
edit
Language Label Description Also known as
English
A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia
scientific article published on 11 December 2014

    Statements

    A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia (English)
    Ninet Sinaii
    Martin J Whitaker
    Lori-Ann Daley
    David J A Eckland
    Carol Van Ryzin
    Richard J Ross
    Deborah P Merke
    11 December 2014
    1137-1145

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit